Drug From Stony Brook-Developed Anti-Cancer Compounds Now in Clinical Trials
November 05, 2026
November 05, 2026
STONY BROOK, New York, Nov. 5 -- The State University of New York Stony Brook University posted the following news:
* * *
Drug From Stony Brook-Developed Anti-Cancer Compounds Now in Clinical Trials
*
The investigational new drug resulted from research on next-generation taxanes in Dr. Iwao Ojima's medicinal chemistry laboratory
STONY BROOK, NY, November 5, 2026 - A promising new cancer chemotherapeutic agent from a taxane cla . . .
* * *
Drug From Stony Brook-Developed Anti-Cancer Compounds Now in Clinical Trials
*
The investigational new drug resulted from research on next-generation taxanes in Dr. Iwao Ojima's medicinal chemistry laboratory
STONY BROOK, NY, November 5, 2026 - A promising new cancer chemotherapeutic agent from a taxane cla . . .
